Ex Vivo Restimulation of Human PBMC Expands a CD3+CD4-CD8-γδ+ T Cell Population That Can Confound the Evaluation of CD4 and CD8 T Cell Responses to Vaccination by B. J. Sedgmen, L. Papalia, L. Wang, A. R. Dyson, H. A. McCallum, C. M. Simson, M. J. Pearse, E. Maraskovsky, D. Hung, P. P. Eomois, G. Hartel, M. J. Barnden, S. P. Rockman

“…During the assessment of cell-mediated immunity (CMI) in subjects participating in a large-scale influenza vaccine trial, we identified the expansion of an IFN-γ-producing CD3+CD4-CD8-γδ+ T cell population in the peripheral blood of 90/610 (15%) healthy subjects. …”
Get full text

Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I by Yukitoshi Takahashi, Kazumi Matsuda, Yuko Kubota, Jiro Shimomura, Etsuko Yamasaki, Tatsuya Kudo, Katsuyuki Fukushima, Hitoshi Osaka, Noriyuki Akasaka, Atsushi Imamura, Shinji Yamada, Naomi Kondo, Tateki Fujiwara

“…In a patient with seizure onset after influenza A infections, cross-reaction of the patient's lymphocytes with GluRε2 and influenza vaccine components was demonstrated by lymphocyte stimulation test. …”
Get full text

Attitude to RSV Vaccination Among a Cohort of Pregnant Women in Jordan: A Cross‐Sectional Survey Study by Malik Sallam, Tleen Kherfan, Amwaj Al‐Farajat, Leen Nemrawi, Nada Atawneh, Rand Fram, Ala'a B. Al‐Tammemi, Muna Barakat, Kamil Fram

“…Variables that were significantly associated with a higher RSV vaccine acceptance in multivariate analysis were: age < 30 years (adjusted odds ratio (aOR): 2.45, p = 0.010), undergraduates (aOR: 3.27, p = 0.026), being a healthcare worker (aOR: 4.50, p = 0.036), and the history of previous COVID‐19/influenza vaccine uptake (aOR: 2.47, p = 0.045). Two out of the six ABCDEF constructs were significantly associated with RSV vaccine acceptance, namely the “Advice” construct (aOR: 10.38, p < 0.001) and the “Fear” construct (aOR: 21.49, p < 0.001). …”
Get full text

Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza by Olivia Prosper, Omar Saucedo, Doria Thompson, Griselle Torres-Garcia, Xiaohong Wang, Carlos Castillo-Chavez

“…The challenges faced by nations dealing jointly with seasonal and novel A-H1N1 co-circulating strains under limited resources, that is, those with no access to novel A-H1N1 vaccine supplies, limited access to the seasonal influenza vaccine, and limited access to antivirals (like Tamiflu) are explored in this study. …”
Get full text

Distinct response patterns of endothelial markers to the BNT162b2 mRNA COVID-19 booster vaccine are associated with the spike-specific IgG antibody production by Beatriz Castro-Robles, Francisco J. Cimas, Francisco J. Cimas, Lourdes Arias-Salazar, Jesús Ontañón, Julia Lozano, Susana López-López, Fernando Andrés-Pretel, María Ángeles Requena-Calleja, Antonio Mas, Antonio Mas, Antonio Mas, Gemma Serrano-Heras, Tomás Segura, Tomás Segura, Javier Solera

“…Incremental and decremental response groups did not differ in terms of age, sex, cardiovascular risk factors, previous SARS-CoV-2 infection and influenza vaccine co-administration. However, these responses were significantly associated with the relative spike-specific antibody production. …”
Get full text

A gram-positive enhancer matrix particles vaccine displaying swine influenza virus hemagglutinin protects mice against lethal H1N1 viral challenge by Yufei Zhang, Yufei Zhang, Yufei Zhang, Pei Zhang, Pei Zhang, Pei Zhang, Xiaoyue Du, Xiaoyue Du, Xiaoyue Du, Xiaona Shi, Xiaona Shi, Xiaona Shi, Jinling Wang, Jinling Wang, Jinling Wang, Shuying Liu, Shuying Liu, Shuying Liu

“…Therefore, there is an urgent need to develop a potent vaccine against EA H1N1.MethodsIn this study, we report the effective intramuscular (i.m.) and/or intranasal (i.n.) vaccination of mice with a subunit influenza vaccine utilizing safe adjuvant gram-positive enhancer matrix (GEM) particles derived from the food-grade bacterium Lactococcus lactis. …”
Get full text

Delivery of dendritic cells targeting 3M2e-HA2 nanoparticles with a CpG adjuvant via lysosomal escape of Salmonella enhances protection against H9N2 avian influenza virus by Futing Jia, Wenfeng Wang, Yawen Tian, Ainul Zahra, Yingkai He, Chongbo Ge, Tongyu Zhang, Mingyue Wang, Jingshuo Gong, Gerui Zhang, Guilian Yang, Wentao Yang, Chunwei Shi, Jianzhong Wang, Haibin Huang, Xin Cao, Yang Zeng, Nan Wang, Zhannan Wang, Chunfeng Wang, Yanlong Jiang

“…Avian influenza virus (AIV) subtype H9N2 still poses a great threat to the poultry farming industry and public health worldwide, and the development of a new influenza vaccine that is safe and conservative and able to address influenza virus mutations is highly promising for application. …”
Get full text

Postinfluenza Vaccination Idiopathic Thrombocytopenic Purpura in Three Elderly Patients by Joji Nagasaki, Masahiro Manabe, Kentaro Ido, Hiroyoshi Ichihara, Yasutaka Aoyama, Tadanobu Ohta, Yoshio Furukawa, Atsuko Mugitani

“…We report the cases of three elderly patients who developed ITP after receiving influenza vaccinations. The platelet count of an 81-year-old woman fell to 27,000/μL after she received an influenza vaccination. …”
Get full text

Should My Patient with Inflammatory Bowel Disease on Immunosuppressive Therapy be Vaccinated against Influenza Virus? by Neeraj Narula, Deborah LR Yamamura, John K Marshall

“…Current research suggests that inactivated influenza vaccines are effective, well tolerated and can be administered safely in most IBD patients. …”
Get full text

Herpes zoster vaccine and the risk of stroke: a population-based cohort study using linked data from the Clinical Practice Research Datalink by Fawziah Marra, Kathryn Richardson, Helen I McDonald, Yoon Kong Loke, Helen Mary Parretti

“…The active comparator comprised 653 373 adults receiving an influenza vaccination between 2013 and 2019 meeting herpes zoster vaccine eligibility. …”
Get full text

Foreword: Prevention of COVID-19, Influenza, and Respiratory Syncytial Virus in At-Risk Populations by Stefan Gravenstein

Get full text

Limited preventive care among Medicaid enrollees with HIV in the US South by Jessica S. Kiernan, Rose S. Bono, Deo Mujwara, Zhongzhe Pan, Bassam Dahman, April D. Kimmel

“…Enrollees received lipid, syphilis, and cervical cancer screenings and influenza vaccination in < 50% and glucose screening in 71.7% of total enrollment-years. …”
Get full text

Is Avian influenza virus still threatening humans? Preventative measures and treatment by Jacek Fordymacki, Ryszard Łagowski, Julia Kosęda, Barbara Fetner

“…As part of preparedness for the next pandemic, specific influenza vaccines are developed and available antiviral drugs are being tested for their effectiveness against strains with pandemic potential. …”
Get full text

Epidemic Analysis and Mathematical Modelling of Influenza with Vaccination. by Musiime, Catherine

Get full text

Post-Vaccination Anaphylaxis in Adults: A Systematic Review and Meta-Analysis by Flavia Pennisi, Anna Carole D’Amelio, Rita Cuciniello, Stefania Borlini, Luigi Mirzaian, Giovanni Emanuele Ricciardi, Massimo Minerva, Vincenza Gianfredi, Carlo Signorelli

“…Most studies focused on influenza vaccines (<i>n</i> = 15). Across all studies, 262 anaphylactic cases were reported, with 153 cases related to influenza vaccines, followed by herpes zoster virus vaccines (38 cases) and yellow fever vaccines (29 cases). …”
Get full text

Routine Immunization of Adults in Canada: Review of the Epidemiology of Vaccine-Preventable Diseases and Current Recommendations for Primary Prevention by Michael D Parkins, Shelly A McNeil, Kevin B Laupland

“…All adult Canadians with significant medical comorbidities or those older than 65 years of age should receive the pneumococcal polysaccharide vaccine and yearly trivalent inactivate influenza vaccines. The present review summarizes the burden of illness of these vaccine-preventable diseases in the Canadian adult population and reviews the current immunization recommendations. …”
Get full text

Vaccination Coverage of the Elderly in Greece: A Cross-Sectional Nationwide Study by Dimitrios Papagiannis, Georgios Rachiotis, Anargiros Mariolis, Efterpi Zafiriou, Konstantinos I. Gourgoulianis

“…On the contrary, influenza vaccination coverage was satisfactory.…”
Get full text

The Expression of IL-6, TNF-α, and MCP-1 in Respiratory Viral Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease by Jingtong Zheng, Yue Shi, Lingxin Xiong, Weijie Zhang, Ying Li, Peter G. Gibson, Jodie L. Simpson, Chao Zhang, Junying Lu, Jingying Sai, Guoqiang Wang, Fang Wang

“…Additionally, VP patients were less likely to have received influenza vaccination. VP patients had a systemic inflammation response involving IL-6, TNF-α, and MCP-1 which may be due to virus-induced activation of macrophages. …”
Get full text

Rapid aging of influenza epidemics in China from 2005/06 to 2016/17: A population-based study by Weibo Tang, Hao Lei, Nan Zhang, Yaojing Wang, Shimeng Cai, Shuyi Ji, Lei Yang, Mengya Yang, Can Chen, Shigui Yang, Dayan Wang, Yuelong Shu

“…This finding highlights the importance of influenza vaccination among older individuals in China.…”
Get full text

Respiratory Virus Vaccines: Pathways to Recommendations and Enhanced Coverage for At-Risk Populations by Stefania Maggi, Odile Launay, Rachel Dawson

Get full text